IRIS
RIZZOLI, Vittorio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.730
EU - Europa 3.408
AS - Asia 1.720
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 3
OC - Oceania 2
Totale 8.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.631
CN - Cina 1.365
IE - Irlanda 757
SE - Svezia 715
FI - Finlandia 704
UA - Ucraina 551
DE - Germania 442
TR - Turchia 253
CA - Canada 99
IT - Italia 98
GB - Regno Unito 61
IN - India 36
SG - Singapore 35
BE - Belgio 30
RO - Romania 25
IR - Iran 22
EU - Europa 15
NL - Olanda 8
SK - Slovacchia (Repubblica Slovacca) 4
ES - Italia 3
HK - Hong Kong 3
NG - Nigeria 2
PL - Polonia 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
CM - Camerun 1
FR - Francia 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
JP - Giappone 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
Totale 8.878
Salva come PNG Salva come JPEG
Città #
Dublin 757
Chandler 711
Jacksonville 654
Beijing 296
Dearborn 253
Ashburn 252
Nanjing 235
Izmir 226
San Mateo 186
Princeton 160
Ann Arbor 141
Wilmington 98
Toronto 94
Shenyang 87
Nanchang 81
Kunming 74
Hebei 65
Düsseldorf 63
Helsinki 63
Jinan 62
Hefei 58
Boardman 57
Shanghai 56
Des Moines 49
Parma 47
Woodbridge 40
New York 38
Changsha 35
Jiaxing 35
Tianjin 34
Bremen 33
Brussels 30
Los Angeles 28
Kocaeli 26
Pune 26
Leawood 25
Guangzhou 24
Seattle 24
Grafing 22
Zhengzhou 20
Hangzhou 19
Norwalk 19
Augusta 18
Ningbo 16
Focsani 15
Mestre 14
Monmouth Junction 13
Ardabil 12
Fremont 12
Haikou 12
Houston 11
Lanzhou 11
Fuzhou 10
Taizhou 10
Timisoara 10
Auburn Hills 8
Borås 8
Chongqing 7
Taiyuan 7
Chengdu 6
Amsterdam 5
Edinburgh 5
Milan 5
Trezzano Sul Naviglio 5
Wuhan 5
Bratislava 4
Cambridge 4
Rockville 4
Sabz 4
Southend 4
Torrile 4
Xian 4
Baotou 3
Chicago 3
Jinhua 3
Madrid 3
Montréal 3
Mumbai 3
Orange 3
Shaoxing 3
Singapore 3
Ahmedabad 2
Bergamo 2
Bologna 2
Changchun 2
Frankfurt am Main 2
Lagos 2
Mountain View 2
New Orleans 2
Pisa 2
Quzhou 2
Rome 2
Sacramento 2
St Louis 2
Taipei 2
Walnut 2
Warsaw 2
Wenzhou 2
Andover 1
Athens 1
Totale 5.619
Salva come PNG Salva come JPEG
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 111
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 100
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 97
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 97
Are the Myeloma bone microevironment cells tumoral or not? 94
Human myeloma cells produce angiopoietin-1 but not angiopoietin-2: potential relationship with myeloma-induced angiogenesis 89
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 89
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 89
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 89
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 87
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 84
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 83
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 83
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 82
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 82
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 81
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 81
Angiopoietins expression by human myeloma cells 77
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 77
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 75
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 73
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. 73
Do human myeloma cells directly produce basic FGF? 73
Angiogenic switch in multiple myeloma patients 72
Angiogenic properties of human myeloma cells: role of angiopoietin system 72
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 72
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 72
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 72
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 72
Expression and role of chemokine receptor CXCR3 in multiple myeloma 70
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 70
Macrophage inflammatory protein (MIP)-3 alpha/CCL20 and its receptor CCR6 are overexpressed in the bone microenvironment and involved in osteoclast formation in multiple myeloma patients. 70
VASCULAR ENDOTHELIAL GROWTH FACTOR SECRETION BY MYELOMA CELLS IS INHIBITED BY DOWN-MODULATING ERK PROTEIN KINASE ACTIVITY 69
Angiopoietin-1 and myeloma-induced angiogenesis 69
Amifostine (WR-2721) selective protection against melphalan genotoxicity 68
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 68
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease 68
Osteopontin is produced by human multiple myeloma cells 67
Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment 66
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 66
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 66
DNA damage by tobacco smoke and some antiblastic drugs evaluated using the Comet assay 65
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 65
Bleomycin Genotoxicity and Amifostine (WR-2721) Cell Protection in Normal Leukocytes versus K562 Tumoral Cells 65
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 65
Paracrine rather than autocrine basic FGF (bFGF) loop in multiple myeloma 64
Beta-catenin depended and independent effects induced by myeloma cells in human and murine osteoblasts and osteoblast progenitors. 63
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 63
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 62
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 62
p29ING4 regulates the production of pro-angiogenic molecules by human myeloma cells in normoxic and hypoxic conditions being involved in myeloma-induced angiogenesis. 62
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 62
Angiogenic switch in multiple myeloma 61
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 61
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 61
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 61
Human myeloma cells produce angiopoietin-1: potential relationship with myeloma-induced angiogenesis 60
Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. 60
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 60
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 60
Human myeloma cells express IL-7 mRNA and secrete IL-7 in presence of IL-6 59
Expression of pro-angiogenetic factors by myeloma cells: role of the angiopoietin system 59
Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: identification of potential therapeutic targets 59
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 59
Multiple myeloma patient with unusual extramedullary involvement 59
Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. 59
Human myeloma cells production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 58
A distintive nuclear morfology in three cases of acute myeloid leukaemia associated with loss HLA-DR expression and FTL3 internal tandem duplication 58
Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value? 58
Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. 58
EPIRUBICIN PLUS G-CSF ELICITED PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IS SIGNIFICANTLY ENHANCED BY AMIFOSTINE 57
Down-modulation of ERK protein kinase activity suppresses human myeloma cell proliferation and myeloma-induced angiogenesis by VEGF inhibition 57
Bone marrow transplantation in patients with acute leukemia 57
Autotransplantation in acute leukemia. 57
The proteasome inhibitor bortezomib affects osteoblastogenesis and bone formation in vitro and in vivo in multiple myeloma patients. 57
HUMAN MYELOMA CELLS EXPRESS THE BONE REGULATING GENE RUNX2/CBFA1 AND PRODUCE OSTEOPONTIN THAT IT IS INVOLVED IN MYELOMA INDUCED ANGIOGENESIS 56
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group 56
Evaluation of amifostine (WR-271) cytoprotection against in vitro bleomycin-induced clastogenicity in human leukocytes by SCGE assay 56
Laparoscopic splenectomy: comments on the surgical technic 56
Clonogenic potential and phenotypic analysis of CD34+ cells mobilized by different chemotherapy regimens 56
RANKL is critically involved in the physiopathology of multiple myeloma 55
IL-7 is produced by myeloma cells in presence of IL-6 55
MYELOMA CELLS BLOCK RUNX2/CBFA1 ACTIVITY IN HUMAN BONE MARROW OSTEOBLAST PROGENITORS AND INHIBIT OSTEOBLAST FORMATION AND DIFFERENTIATION 54
Down-modulation of ERK protein kinase activity inhibits vascular endothelial growth factor (VEGF) secretion by human myeloma cell lines 54
Non-infusional vs intravenous consolidation chemotherapy in elderly patients withacute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase 54
Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients 53
Basic fibroblast growth factor (bFGF) production and role in multiple myeloma patients 52
TRAPIANTO DI CELLULE STAMINALI EMOPOIETICHE 52
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. 52
Targeting pathways mediating bone disease. 52
DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status. 52
Gamma-rays from Mössbauer sources: a low-dose approach to cancer therapy 51
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing 51
CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF. 51
Role of tumor necrosis factor-related activation-induced cytokine (TRANCE) in multiple myeloma 50
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 50
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 50
Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment? 49
New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL) 49
Human myeloma cells express interleukin-7 (IL-7) mRNA and secrete IL-7 in presence of IL-6: role in multiple myeloma physiopathology 49
Totale 6.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019328 0 0 0 0 0 0 0 0 0 0 273 55
2019/20202.040 368 346 125 18 163 178 258 35 156 192 54 147
2020/20211.166 21 142 113 4 157 6 120 9 274 37 254 29
2021/2022784 11 2 5 56 16 31 94 137 35 85 80 232
2022/20232.743 357 295 171 193 250 284 53 151 891 11 74 13
2023/2024687 40 105 21 16 75 196 82 89 22 41 0 0
Totale 8.971